SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-049322
Filing Date
2022-02-23
Accepted
2022-02-23 08:45:31
Documents
12
Period of Report
2022-02-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d256251d8k.htm   iXBRL 8-K 24265
  Complete submission text file 0001193125-22-049322.txt   145211

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sppi-20220218.xsd EX-101.SCH 2855
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE sppi-20220218_lab.xml EX-101.LAB 17996
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sppi-20220218_pre.xml EX-101.PRE 11261
6 EXTRACTED XBRL INSTANCE DOCUMENT d256251d8k_htm.xml XML 3409
Mailing Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052
Business Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052 702-835-6300
SPECTRUM PHARMACEUTICALS INC (Filer) CIK: 0000831547 (see all company filings)

IRS No.: 930979187 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35006 | Film No.: 22660761
SIC: 2834 Pharmaceutical Preparations